Walleye Capital LLC Rigel Pharmaceuticals Inc Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.67 - $3.19 $702,869 - $3.35 Million	-1,049,059 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $709,871 - $1.1 Million	319,762 Added 43.85%	1,049,059 $3.14 Million
Q4 2021 Mar 03, 2022	BUY	$2.36 - $3.57 $1.72 Million - $2.6 Million	729,297 New	729,297 $1.93 Million
Q3 2020 Nov 16, 2020	SELL	$1.78 - $4.13 $51,620 - $119,770	-29,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $40,890 - $59,449	29,000 New	29,000 $53,000
Q1 2019 May 15, 2019	SELL	$2.0 - $2.65 $303,846 - $402,595	-151,923 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $394,999 - $545,403	151,923 New	151,923 $488,000

345K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $4.74B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.